Evidence map›Paper›PMID 25953118›Full record

ArticleAIDS research and human retroviruses2015

Intrapatient Evolutionary Dynamics of Human Immunodeficiency Virus Type 1 in Individuals Undergoing Alternative Treatment Strategies with Reverse Transcriptase Inhibitors.

Jonathan K Kayondo, Nicaise Ndembi, Chris M Parry, Patricia A Cane, Stephane Hué, Ruth Goodall, David T Dunn, Pontiano Kaleebu, Deenan Pillay, Jean L Mbisa and 1 more

Open access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jonathan K Kayondo1 Uganda Virus Research Institute (UVRI) , Uganda Research Unit on AIDS, Entebbe, Uganda .
Nicaise Ndembi2 Medical Research Council (MRC)/UVRI , Uganda Research Unit on AIDS, Entebbe, Uganda .
Chris M Parry2 Medical Research Council (MRC)/UVRI , Uganda Research Unit on AIDS, Entebbe, Uganda .
Patricia A Cane3 Virus Reference Department, Public Health England , London, United Kingdom .
Stephane Hué4 Department of Infection and Immunity, University College London , London, United Kingdom .
Ruth Goodall5 MRC Clinical Trials Unit, University College London , London, United Kingdom .
David T Dunn5 MRC Clinical Trials Unit, University College London , London, United Kingdom .
Pontiano Kaleebu1 Uganda Virus Research Institute (UVRI) , Uganda Research Unit on AIDS, Entebbe, Uganda .
Deenan Pillay4 Department of Infection and Immunity, University College London , London, United Kingdom .
Jean L Mbisa3 Virus Reference Department, Public Health England , London, United Kingdom .
DART Virology Committee
University College London · GBPublic Health England · GBUganda Virus Research Institute · UGMRC Clinical Trials Unit at UCL · GB

Funding

Medical Research Council MC_UU_12023/23Medical Research Council MR/K006584/1Wellcome Trust 084344Wellcome Trust 097410
6 · The paper itself

Abstract

Structured treatment interruption (STI) has been trialed as an alternative to lifelong antiretroviral therapy (ART). We retrospectively performed single genome sequencing of the HIV-1 pol region from three patients representing different scenarios. They were either failing on continuous therapy (CT-F), failing STI (STI-F), or suppressing on STI (STI-S). Over 460 genomes were generated from three to five different time points over a 2-year period. We found multiple-linked-resistant mutations in both treatment failures. However, the CT-F patient showed a stepwise accumulation of diverse, linked mutations whereas the STI-F patient had lineage turnover between treatment periods with recirculation of wild-type and resistant variants from reservoirs. The STI-F patient showed a 7-fold increase in the third codon position substitution rate relative to the first and second positions compared to a 2-fold increase for CT-F and increased purifying selection in the pol gene (62 vs. 22 sites, respectively). An understanding of intrapatient viral dynamics could guide the future direction of treatment interruption strategies.

Indexed as

Genetic VariationAdaptation, BiologicalAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveCluster AnalysisEvolution, MolecularGenome, ViralGenotypeHIV-1HIV InfectionsHumansMolecular Sequence DataPhylogenypol Gene Products, Human Immunodeficiency VirusRetrospective StudiesReverse Transcriptase InhibitorsAnti-HIV Agentspol Gene Products, Human Immunodeficiency VirusReverse Transcriptase Inhibitors

Identifiers

PMID25953118
PMCPMC4505773
OpenAlexW1828454416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.